Skip to content
DraconiticResearch
Search Sources API
194,230 studies31 sourcesUpdated 50 min ago
PreprintCC BY-NC-NDChemRxiv

Same Substitutions, Opposite Residence Times: Target-Dependent Kinetic Inversion of Diazabicyclooctane 𝛽-Lactamase Inhibitors

  1. 1Faculty of Medicine
  2. 2Mansoura University
  3. 3Faculty of Pharmacy

Abstract

Reversible covalent inhibitors are governed by both formation and breakdown of the covalent complex, yet matched medicinal-chemistry modifications are often interpreted through affinity or potency alone. We performed an original quantitative reanalysis of published experimental kinetics and corresponding covalent crystal structures for four diazabicyclooctane (DBO) inhibitors—avibactam, FPI-1465, FPI-1523, and FPI-1602—against CTX-M-15 and OXA-48. Relative to avibactam, all three C2-modified analogues showed lower 𝑘2/𝐾𝑖 in both enzymes, but their effects on dissociation reversed sign between targets. FPI-1465, FPI-1523, and FPI-1602 dissociated 3.86-, 3.38-, and 4.91-fold more slowly from CTX-M-15, whereas they dissociated 68.8-, 3.12-, and 2.73-fold more rapidly from OXA-48. The corresponding cross-target interactions were 265.5-, 10.5-, and 13.4-fold. Eyring transformation mapped these effects to shifts in the reverse activation barrier of +0.72 to +0.94 kcal mol−1 in CTX-M-15 versus −0.59 to −2.51 kcal mol−1 in OXA-48. Static oxyanion-hole geometry did not encode the OXA-48 ranking: mean donor–carbonyl-oxygen distances changed by only 0.002–0.065 Å relative to avibactam despite 2.7–68.8-fold changes in 𝑘off. These findings identify a replicated target-dependent residence-time inversion and demonstrate that forward and reverse structure–kinetic relationships can diverge within a matched reversible-covalent series. Conformational ensembles and distributed electrostatics emerge as specific prospective mechanisms, but are not inferred as causal from the present static-structure analysis.

Related

  1. SGLT2 inhibitors attenuate diabetic kidney disease by suppressing YAP dependent ferroptosis
    Lan Feng, Chunni Feng, Huirong Li +4
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  2. Remnant Lipoproteins as Dynamic Metabolic States: A Residence Time–Based Framework for TRL Metabolism
    Katsuyuki Nakajima, Masami Murakami, Akira Tanaka
    Journal of Lipid ResearchPeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref
  3. Residence-based inequalities among women and girls aged 15–49 years using reusable and single-use menstrual materials in Ghana: a cross-sectional study
    Patience Fakornam Doe, Yula Salifu, Joseph Lasong +5
    Frontiers in reproductive healthPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Nativity and US Residence Duration and Colorectal Cancer Screening Nonadherence.
    Sebastian O Ekenze, Areesh Mevawalla, Aayan E Kibria +3
    JAMA network openPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCCrossref
  5. New Residence-Based Formula for Ryan White HIV/AIDS Program Funding: Projected Jurisdictional Impacts, 2025-2030.
    Reanna K Panagides, Erin Q Rogers, Amy Killelea +5
    Open forum infectious diseasesPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
BibTeX
@misc{fouda2026same,
  title = {{Same Substitutions, Opposite Residence Times: Target-Dependent Kinetic Inversion of Diazabicyclooctane 𝛽-Lactamase Inhibitors}},
  author = {Abdel-Motaal M. Fouda and Dina A. Fouda},
  howpublished = {ChemRxiv},
  year = {2026},
  month = sep,
  doi = {10.26434/chemrxiv.15008332/v1},
  url = {https://chemrxiv.org/doi/full/10.26434/chemrxiv.15008332/v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Same Substitutions, Opposite Residence Times: Target-Dependent Kinetic Inversion of Diazabicyclooctane 𝛽-Lactamase Inhibitors
AU  - Abdel-Motaal M. Fouda
AU  - Dina A. Fouda
PY  - 2026
DA  - 2026/09/04
PB  - ChemRxiv
DO  - 10.26434/chemrxiv.15008332/v1
UR  - https://chemrxiv.org/doi/full/10.26434/chemrxiv.15008332/v1
AB  - Reversible covalent inhibitors are governed by both formation and breakdown of the covalent complex, yet matched medicinal-chemistry modifications are often interpreted through affinity or potency alone. We performed an original quantitative reanalysis of published experimental kinetics and corresponding covalent crystal structures for four diazabicyclooctane (DBO) inhibitors—avibactam, FPI-1465, FPI-1523, and FPI-1602—against CTX-M-15 and OXA-48. Relative to avibactam, all three C2-modified analogues showed lower 𝑘2/𝐾𝑖 in both enzymes, but their effects on dissociation reversed sign between targets. FPI-1465, FPI-1523, and FPI-1602 dissociated 3.86-, 3.38-, and 4.91-fold more slowly from CTX-M-15, whereas they dissociated 68.8-, 3.12-, and 2.73-fold more rapidly from OXA-48. The corresponding cross-target interactions were 265.5-, 10.5-, and 13.4-fold. Eyring transformation mapped these effects to shifts in the reverse activation barrier of +0.72 to +0.94 kcal mol−1 in CTX-M-15 versus −0.59 to −2.51 kcal mol−1 in OXA-48. Static oxyanion-hole geometry did not encode the OXA-48 ranking: mean donor–carbonyl-oxygen distances changed by only 0.002–0.065 Å relative to avibactam despite 2.7–68.8-fold changes in 𝑘off. These findings identify a replicated target-dependent residence-time inversion and demonstrate that forward and reverse structure–kinetic relationships can diverge within a matched reversible-covalent series. Conformational ensembles and distributed electrostatics emerge as specific prospective mechanisms, but are not inferred as causal from the present static-structure analysis.
ER  -